Does Wegovy affect libido? What the research shows

The myth worth correcting first: Wegovy is not listed as a cause of reduced libido

The most common assumption people bring to this question is that Wegovy must be suppressing libido the way some antidepressants or hormonal medicines do. That is not what the licensed prescribing information says. The NHS semaglutide medicines page lists the recognised side effects of semaglutide: nausea, vomiting, diarrhoea, constipation, headache, dizziness, fatigue and injection-site reactions. Reduced libido does not appear. Semaglutide works as a GLP-1 receptor agonist, acting on appetite-regulating pathways and slowing gastric emptying; it does not directly interact with sex hormones or the neural pathways that govern sexual desire.

That does not mean everyone's sex drive stays constant throughout treatment. It means the medicine itself is unlikely to be the direct cause when changes do occur. The more productive question is what else is happening in someone's body and life during significant weight loss, because quite a lot is.

If you want a thorough look at the evidence from the patient side, the page on how semaglutide affects libido covers the mechanistic detail, and our Wegovy low libido page addresses what to do if you do notice a change.

Weight loss itself reshapes hormones, often in the direction that helps libido

Obesity is associated with measurable hormonal disruption. In men, excess adipose tissue converts testosterone to oestrogen through a process called aromatisation, which can suppress circulating testosterone levels significantly. Research published in clinical endocrinology literature consistently links higher BMI with lower free testosterone and reduced sexual function in men. As body fat falls, that aromatisation burden falls with it, and testosterone can recover. For some men on Wegovy, the net hormonal effect of losing 10–15% of body weight is an improvement in sex drive rather than a reduction, the opposite of what people expect.

For women, the picture is similarly complex. Weight loss can improve polycystic ovarian syndrome (PCOS) symptoms, reduce insulin resistance and restore hormonal balance, all of which have downstream effects on sexual wellbeing. Improved energy, reduced joint pain and better sleep (all plausible outcomes of sustained weight loss) contribute to sexual function in ways that are hard to isolate from the medicine's direct pharmacology. The specific effects of Wegovy on libido in women are worth reading if that is your situation, as the hormonal interplay differs.

The STEP 1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 15% over 68 weeks with semaglutide 2.4mg alongside lifestyle support. Changes of that magnitude carry real physiological consequences for hormone profiles, consequences the trial's primary endpoints were not designed to measure, but which are biologically plausible and consistent with what patients report.

What can genuinely suppress libido during Wegovy treatment, and it is not always the pen

Several factors that commonly accompany starting Wegovy can affect sex drive, and none of them are permanent. Nausea is the most frequently reported side effect, particularly in the first weeks of each dose step. Feeling persistently nauseous makes intimacy unappealing for straightforward reasons that have nothing to do with hormones. Fatigue is similarly common early in treatment. The psychological weight of changing your diet, adjusting to injections and monitoring your progress creates its own cognitive load.

Caloric restriction (a central part of weight management alongside any medicine) can temporarily reduce energy levels and, by extension, sexual energy. If intake drops sharply, that effect amplifies. This is why the clinical guidance accompanying Wegovy consistently emphasises adequate protein, hydration and physical activity, not just calorie reduction. Our Wegovy overview covers what the treatment programme involves day to day.

Body image shifts during weight loss are also not straightforward. Some people feel more confident quickly; others find the transition unsettling, especially if change is rapid or uneven. Both responses are normal. A question our prescribers hear from time to time is whether these emotional adjustments are something the medicine is causing, usually the honest answer is that the medicine created the conditions for change, and the person is doing the adjusting. If low mood or significant emotional difficulty appears during treatment, that is worth raising with your prescriber promptly rather than attributing it silently to Wegovy.

You can read more about the broader effects of semaglutide on the semaglutide overview page, or explore the full range of treatment options on our weight-loss treatments page.

Wegovy and libido in men: the testosterone connection in plain terms

For men specifically, the relationship between Wegovy and libido is particularly worth understanding before assuming the worst. The evidence base for testosterone improving alongside significant weight loss is solid enough that some clinicians consider weight management a first-line intervention for hypogonadism related to obesity, before considering testosterone replacement. Losing weight through any means (diet alone, surgery, or medicines including semaglutide) can raise free testosterone meaningfully. Wegovy in men therefore sits in an unusual position: the medicine facilitates a degree of weight loss that can improve the very thing people worry it might worsen.

That said, individual responses vary. Age, baseline hormone levels, the presence of conditions like type 2 diabetes, cardiovascular disease, and the speed of weight loss all modify outcomes. No general statement covers everyone. This is one reason the frequently asked questions section of our site gets this topic regularly, the answer genuinely depends on the individual's clinical profile, which is exactly what a prescriber reviews.

Wegovy is a prescription-only medicine. If libido changes during treatment concern you, the right move is to discuss them with whoever oversees your care, whether that is a GP or the prescriber at your online pharmacy. At nume, prescribers are available for aftercare queries seven days a week. If you are considering starting treatment, our guide to Wegovy is a useful first read, and a free consultation with our clinical team is the place to begin, a real prescriber reviews every assessment, not an automated system.